Accès ouvert
2022
erratum
OpenAlex
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking et autres
An amendment to this paper has been published and can be accessed via the original article.
de
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking et autres
BACKGROUND: Histone acetylation and deacetylation seem processes involved in the pathogenesis of Ewing sarcoma (EwS). Here histone deacetylases (HDAC) class I were investigated. METHODS: Their role was determined using different inhibitors including TSA, Romidepsin, Entinostat and PCI-34051 as well as CRISPR/Cas9 class …
de
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking et autres
de
(code pays fourni par la source)
Accès ouvert
2021
dataset
OpenAlex
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking et autres
Additional file 3: Fig. S9. Whole Western blots with molecular weight markers in selected figures.
Accès ouvert
2021
dataset
OpenAlex
Oxana Schmidt, Nadja Nehls, Carolin Prexler, Kristina von Heyking et autres
Additional file 2: Fig. S1 a, Expression levels of different class I HDAC genes in different pediatric small-round-blue-cell tumors, carcinomas and normal tissues by box plot presentation using a comparative study of the amc onco-genomics software tool ( https://hgserver1.amc.nl/cgi-bin/r2/main.cgi ). The number …
Accès ouvert
2020
article
OpenAlex
Günther H.S. Richter, Tim Hensel, Oxana Schmidt, Vadim Saratov et autres
BACKGROUND: Previously, we used inhibitors blocking BET bromodomain binding proteins (BRDs) in Ewing sarcoma (EwS) and observed that long term treatment resulted in the development of resistance. Here, we analyze the possible interaction of BRD4 with cyclin-dependent kinase (CDK) 9. METHODS: Co-immunoprecipitation …
de, ch, au
(code pays fourni par la source)
2018
conference-abstract
OpenAlex
David Schirmer, Isabel Storz, Karin Wisskirchen, Regina Feederle et autres
Abstract Introduction: Pediatric cancers, including Ewing sarcoma (EwS), are only weakly immunogenic and the tumor patient’s immune system often is devoid of effector T cells for tumor elimination. Based on expression profiling technology, targetable tumor-associated antigens (TAA) are identified and exploited for …
de
(code pays fourni par la source)
2018
conference-abstract
OpenAlex
Tim Hensel, Chiara Giorgi, Oxana Schmidt, Hsi-Yu Yen et autres
Abstract Introduction: Ewing sarcomas (EwS) are highly malignant bone or soft tissue tumors. Genetically, EwS are defined by balanced chromosomal EWSR1/ETS translocations, which give rise to chimeric proteins (EWSR1-ETS) that generate an oncogenic transcriptional program associated with altered epigenetic marks throughout the …
de, au
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Johannes Wischmann, Florian Walter Lenze, Antonia Thiel, Sakina Bookbinder et autres
Osteoblasts are adherent cells, and under physiological conditions they attach to both mineralized and non-mineralized osseous surfaces. However, how exactly osteoblasts respond to these different osseous surfaces is largely unknown. Our hypothesis was that the state of matrix mineralization provides a functional …
de, us
(code pays fourni par la source)
2018
conference-abstract
OpenAlex
Oxana Schmidt, Nadja Nehls, Kristina von Heyking, Tim Hensel et autres
Abstract Introduction: Recent evidence demonstrated that a low mutation rate seems a general feature of pediatric cancers. Ewing sarcoma (EwS) is defined by balanced chromosomal EWS/ETS translocations, which give rise to oncogenic chimeric proteins (EWS-ETS). Previously, we identified the histone methyl-transferase enhancer …
de
(code pays fourni par la source)
2018
conference-abstract
OpenAlex
Uwe Thiel, Sebastian Johannes Schober, Ingo Einspieler, A. Kirschner et autres
Abstract Background: Chondromodulin-I (CHM1) sustains malignancy in Ewing sarcoma (ES). Refractory ES carries a dismal prognosis and patients with bone-marrow (BM) metastases do not survive irrespective of therapy. We assessed HLA-A*02:01/CHM1 specific allorestricted T-cell receptor (TCR) wild-type and transgenic cytotoxic (CD8+) T …
2018
conference-abstract
OpenAlex
Tim Hensel, Chiara Giorgi, Fiona AG Becker-Dettling, Julia Calzada‐Wack et autres
Abstract Introduction: We reported blocking of BET bromodomain binding proteins (BRDs) by use of an inhibitor (JQ1) and the associated strong downregulation of the predominant EWS-ETS protein EWS-FLI1 in Ewing sarcoma (ES). Here we analyzed in depth the mechanistic effects of this …
de, ch, au
(code pays fourni par la source)